TME Pharma N.V. (EPA:ALTME)
France · Delayed Price · Currency is EUR 0.1106
+0.0002 (0.18%)
Oct 23, 2026, 9:10 AM CEST
TME Pharma Revenue
TME Pharma had revenue of -27.00K EUR in the half year ending December 31, 2025. That makes TME Pharma the 46,822nd largest company in the world by revenue and 629th in France.
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
12
Market Cap
10.41M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 33.00K | -2.00K | -5.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 24.58M |
| Advicenne | 10.74M |
| Poxel | 7.66M |
| MaaT Pharma | 3.18M |
| Aelis Farma | 2.19M |
| Oncodesign Precision Medicine Société anonyme | 1.81M |
| Aton | 661.00K |
| NFL Biosciences | 188.00 |
TME Pharma News
- 5 weeks ago - TME Pharma Surges Over 20% On CEO Statement, Plans Phase 2 For NOX-A12 In Glioma - Nasdaq